- Like what you see? Let's talk
Healthcare Payers and Providers Manage Transition and Reduce Costs with iTransform
Bangalore, India – June 15, 2009
Infosys Technologies Limited (NASDAQ: INFY) today introduced the iTransform™ Product Suite, which delivers an end-to-end offering for managing the transitions to the 5010 version of the HIPAA standard transactions and ICD-10 coding systems. By taking a comprehensive approach for assessment and remediation, and automating a significant amount of the transition exercise, based on prototype results the iTransform Product Suite can help healthcare payers and providers save up to 50 percent of the cost and up to 50 percent of the duration to make the transitions compared to the manual process and remediation.
"Healthcare organizations face one of the most significant challenges to the U.S. healthcare industry in decades in order to comply with HIPAA 5010 and ICD-10 regulations," said Eric Paternoster, senior vice president and head of insurance, healthcare and life sciences, Infosys Technologies. "iTransform not only simplifies transition, it also delivers an opportunity for payers and providers to take advantage of the new regulations for improving operational efficiency, reducing costs and providing better healthcare."
The iTransform Product Suite uses tools and accelerators to accelerate every phase of transition while lowering the cost and risk of manual analysis and remediation. The suite consists of a collection of well-defined components that work in tandem to provide a complete solution from assessment to implementation:
Each component can work in isolation and targets a specific need such as code analysis for custom applications, rating engine neutralization and ICD crosswalks. These components, though self-contained and available on an individual basis, work together toward an accelerated transition to HIPAA 5010 and ICD10 and continued smooth operations post transition.
To learn more about the iTransform Product Suite, please visit: https://www.infosys.com/industries/healthcare/industry-offerings/icd-transition-services.html
Infosys (NASDAQ: INFY) defines, designs and delivers IT-enabled business solutions that help Global 2000 companies win in a Flat World. These solutions focus on providing strategic differentiation and operational superiority to clients. With Infosys, clients are assured of a transparent business partner, world-class processes, speed of execution and the power to stretch their IT budget by leveraging the Global Delivery Model that Infosys pioneered. Infosys has over 1,00,000 employees in over 50 offices worldwide. Infosys is part of the NASDAQ-100 Index and The Global Dow. For more information, visit www.infosys.com
Statements in connection with this release may include forward-looking statements within the meaning of US Securities laws intended to qualify for the "safe harbor" under the Private Securities Litigation Reform Act. These forward-looking statements are subject to risks and uncertainties including those described in our SEC filings available at www.sec.gov including our Annual Report on Form 20-F for the year ended March 31, 2008, and our other recent filings, and actual results may differ materially from those projected by forward-looking statements. We may make additional written and oral forward-looking statements but do not undertake, and disclaim any obligation, to update them.
For further information, please contact: PR_Global@infosys.com